Wu L - Search Results

1

Tumor cell repopulation between cycles of chemotherapy is inhibited by regulatory T-cell depletion in a murine mesothelioma model.

Wu L, Yun Z, Tagawa T, Rey-McIntyre K, Anraku M, de Perrot M. Wu L, et al. J Thorac Oncol. 2011 Sep;6(9):1578-86. doi: 10.1097/JTO.0b013e3182208ee0. J Thorac Oncol. 2011. PMID: 21642867 Free article.

2

Repopulation in murine breast tumors during and after sequential treatments with cyclophosphamide and 5-fluorouracil.

Wu L, Tannock IF. Wu L, et al. Cancer Res. 2003 May 1;63(9):2134-8. Cancer Res. 2003. PMID: 12727830

3

Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts.

Wu L, Birle DC, Tannock IF. Wu L, et al. Cancer Res. 2005 Apr 1;65(7):2825-31. doi: 10.1158/0008-5472.CAN-04-3137. Cancer Res. 2005. PMID: 15805283

4

Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapy.

Wu L, Tannock IF. Wu L, et al. Clin Cancer Res. 2005 Nov 15;11(22):8195-200. doi: 10.1158/1078-0432.CCR-05-1258. Clin Cancer Res. 2005. PMID: 16299252

5

Concurrent and sequential administration of chemotherapy and the Mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts.

Fung AS, Wu L, Tannock IF. Fung AS, et al. Among authors: wu l. Clin Cancer Res. 2009 Sep 1;15(17):5389-95. doi: 10.1158/1078-0432.CCR-08-3007. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706800

6

Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.

Anraku M, Tagawa T, Wu L, Yun Z, Keshavjee S, Zhang L, Johnston MR, de Perrot M. Anraku M, et al. Among authors: wu l. J Immunol. 2010 Jul 15;185(2):956-66. doi: 10.4049/jimmunol.0900437. Epub 2010 Jun 14. J Immunol. 2010. PMID: 20548032

7

CTLA-4 blockade expands infiltrating T cells and inhibits cancer cell repopulation during the intervals of chemotherapy in murine mesothelioma.

Wu L, Yun Z, Tagawa T, Rey-McIntyre K, de Perrot M. Wu L, et al. Mol Cancer Ther. 2012 Aug;11(8):1809-19. doi: 10.1158/1535-7163.MCT-11-1014. Epub 2012 May 14. Mol Cancer Ther. 2012. PMID: 22584123

8

Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.

Tagawa T, Wu L, Anraku M, Yun Z, Rey-McIntyre K, de Perrot M. Tagawa T, et al. Among authors: wu l. J Immunother. 2013 Oct;36(8):391-9. doi: 10.1097/CJI.0b013e3182a801f2. J Immunother. 2013. PMID: 23994885

9

Metabolomic heterogeneity of pulmonary arterial hypertension.

Zhao Y, Peng J, Lu C, Hsin M, Mura M, Wu L, Chu L, Zamel R, Machuca T, Waddell T, Liu M, Keshavjee S, Granton J, de Perrot M. Zhao Y, et al. Among authors: wu l. PLoS One. 2014 Feb 12;9(2):e88727. doi: 10.1371/journal.pone.0088727. eCollection 2014. PLoS One. 2014. PMID: 24533144 Free PMC article.

10

Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.

Sui W, Zhang Y, Wang Z, Wang Z, Jia Q, Wu L, Zhang W. Sui W, et al. Among authors: wu l. Oncol Rep. 2014 May;31(5):2252-60. doi: 10.3892/or.2014.3093. Epub 2014 Mar 19. Oncol Rep. 2014. PMID: 24647425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,234 results

Search Page

Filters